tiprankstipranks
Helus Pharma (HELP)
NASDAQ:HELP
US Market
HELP
Helus Pharma
RESEARCH TOOLSreports

Helus Pharma (HELP) Income Statement

2,564 Followers

Helus Pharma Income Statement

Last quarter (Q1 2027), Helus Pharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Helus Pharma's net income was C$-46.60M. See Helus Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Jun 25Mar 24Mar 23Mar 22
Total Revenue
$ -44.68MC$ 472.27KC$ 0.00C$ 251.01KC$ 167.76K
Gross Profit
$ -44.80MC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
$ 96.87MC$ 143.15MC$ 78.84MC$ 51.52MC$ 63.84M
Depreciation and Amortization
$ 120.00KC$ 211.00KC$ 424.00KC$ 251.00KC$ 168.00K
EBITDA
$ -141.56MC$ -142.94MC$ -78.41MC$ -51.27MC$ -63.67M
Operating Income
$ -141.68MC$ -143.15MC$ -78.84MC$ -51.52MC$ -63.84M
Other Income/Expenses
$ 83.99MC$ 29.54MC$ 756.00KC$ 3.78MC$ -3.96M
Pretax Income
$ -57.69MC$ -113.61MC$ -78.08MC$ -47.74MC$ -67.80M
Net Income
$ -147.05MC$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63M
Per Share Metrics
Basic EPS
$ -4.23C$ -5.59C$ -3.91C$ -9.73C$ -15.36
Diluted EPS
$ -4.23C$ -5.59C$ -9.41C$ -9.74C$ -15.36
Weighted Average Shares Outstanding
 34.80M 20.22M 20.00M 4.88M 4.40M
Weighted Average Shares Outstanding (Diluted)
 34.80M 20.22M 20.00M 4.88M 4.40M

Helus Pharma Earnings and Revenue History